Menu
← Oncology Approval Tracker
FDA DECISION ·
Jemperli
dostarlimab-gxly · GlaxoSmithKline
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with recurrent or advanced dMMR solid tumors by an FDA-approved test, with progression during or after prior treatment and no satisfactory alternatives.
LAMPGEN ANALYSIS
Why it matters
This is a biomarker-defined solid tumor indication across primary sites.
What research teams should watch
Capture the primary tumor, MMR method and clinical assessment of alternative treatments.
PRIMARY RECORDS